Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionAvestar Capital, LLC
Latest Disclosed Ownership19,227 shares
Latest Disclosed Value $ 2,679,718
Avestar Capital, LLC reports 11.77% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 13, 2026 - Avestar Capital, LLC filed a 13F-HR form disclosing ownership of 19,227 shares of Gilead Sciences, Inc. (US:GILD) valued at $2,679,667 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 21,793 shares of Gilead Sciences, Inc.. This represents a change in shares of -11.77% during the quarter. The current value of the position is $2,480,091 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 19,227 -2,566 -11.77 2,680 0.19 0.1721
2026-02-10 2025-12-31 13F GILEAD SCIENCES COM 375558103 21,793 2,639 13.78 2,675 25.78 0.1733
2025-11-07 2025-09-30 13F GILEAD SCIENCES COM 375558103 19,154 1,040 5.74 2,126 5.88 0.1392
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM 375558103 18,114 4,296 31.09 2,008 29.72 0.1372
2025-05-14 2025-03-31 13F GILEAD SCIENCES COM 375558103 13,818 5,521 66.54 1,548 102.09 0.1344
2025-01-29 2024-12-31 13F GILEAD SCIENCES COM 375558103 8,297 1,362 19.64 766 31.84 0.0651
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 6,935 1,534 28.40 581 57.03 0.0598
2024-08-08 2024-06-30 13F GILEAD SCIENCES COM 375558103 5,401 568 11.75 371 4.52 0.0381
2024-05-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 4,833 -235 -4.64 354 -13.66 0.0371
2024-02-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 5,068 1,274 33.58 411 44.37 0.0465
2023-10-20 2023-09-30 13F GILEAD SCIENCES COM 375558103 3,794 694 22.39 284 19.33 0.0404
2023-08-02 2023-06-30 13F GILEAD SCIENCES COM 375558103 3,100 596 23.80 239 14.98 0.0383
2023-04-20 2023-03-31 13F GILEAD SCIENCES COM 375558103 2,504 -168 -6.29 208 -9.61 0.0371
2023-01-20 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,672 2,672 229 0.0415
2021-08-03 2021-06-30 13F GILEAD SCIENCES COM 375558103 0 -3,472 -100.00 0 -100.00
2021-05-03 2021-03-31 13F GILEAD SCIENCES COM 375558103 3,472 3,472 224 0.0500
2020-10-29 2020-09-30 13F GILEAD SCIENCES COM 375558103 0 -4,677 -100.00 0 -100.00
2020-07-29 2020-06-30 13F GILEAD SCIENCES COM 375558103 4,677 -7,476 -61.52 360 -60.40 0.1591
2020-05-12 2020-03-31 13F GILEAD SCIENCES COM 375558103 12,153 355 3.01 909 18.67 0.4966
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 11,798 -325 -2.68 766 -0.26 0.4327
2019-11-15 2019-09-30 13F/A-1 GILEAD SCIENCES INC COM USD0.001 COM 375558103 12,123 226 1.90 768 -3.76 0.4775
2019-11-14 2019-09-30 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 12,123 226 768 0.4775
2019-08-06 2019-06-30 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 11,897 5 0.04 798 3.77 0.5057
2019-05-09 2019-03-31 13F GILEAD SCIENCES INC COM USD0.001 COM 375558103 11,892 26 0.22 769 4.06 0.5050
2019-01-25 2018-12-31 13F GILEAD SCIENCES COM 375558103 11,866 -2 -0.02 739 -19.06 0.5049
2018-10-23 2018-09-30 13F GILEAD SCIENCES COM 375558103 11,868 -166 -1.38 913 7.54 0.5279
2018-08-10 2018-06-30 13F GILEAD SCIENCES COM 375558103 12,034 -9 -0.07 849 -6.08 0.5368
2018-05-10 2018-03-31 13F GILEAD SCIENCES COM 375558103 12,043 51 0.43 904 5.73 0.5877
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 11,992 11,992 855 0.6389
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.